Patents by Inventor Bernd Buchberger

Bernd Buchberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11098298
    Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: August 24, 2021
    Assignee: BIOMÉRIEUX DEUTSCHLAND GMBH
    Inventors: Bernd Buchberger, Holger Grallert, Sonja Molinaro
  • Patent number: 11092592
    Abstract: The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.
    Type: Grant
    Filed: January 30, 2020
    Date of Patent: August 17, 2021
    Assignee: BIOMÉRIEUX DEUTSCHLAND GMBH
    Inventor: Bernd Buchberger
  • Patent number: 10655113
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: May 19, 2020
    Assignee: HYPHARM GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Patent number: 10585086
    Abstract: The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: March 10, 2020
    Assignee: HYGLOS INVEST GMBH
    Inventor: Bernd Buchberger
  • Patent number: 10323238
    Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: June 18, 2019
    Assignee: HYGLOS INVEST GMBH
    Inventors: Bernd Buchberger, Holger Grallert, Sonja Molinaro
  • Patent number: 10301607
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonization and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Grant
    Filed: January 20, 2016
    Date of Patent: May 28, 2019
    Assignee: HYPHARM GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Patent number: 9725706
    Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harboring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: August 8, 2017
    Assignee: HYGLOS INVEST GMBH
    Inventors: Bernd Buchberger, Holger Grallert, Sonja Molinaro
  • Patent number: 9453842
    Abstract: The present invention deals with reagents and compositions capable of effectively inhibiting peroxidase activity. According to the invention, peroxidase enzymatic activity is blocked with an acidic aqueous solution of a protein denaturing agent. Preferred protein denaturing agents are detergents and chaotropic substances.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: September 27, 2016
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Manfred Watzele, Bernd Buchberger, Claudia Kirr
  • Publication number: 20160137993
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Application
    Filed: January 20, 2016
    Publication date: May 19, 2016
    Applicant: HYGLOS INVEST GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Patent number: 9249447
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonization and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: February 2, 2016
    Assignee: HYGLOS INVEST GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Patent number: 8951780
    Abstract: The invention concerns a method for isolating and purifying nucleic acids from large sample volumes and a device suitable for this. The device comprises a funnel, a separating column, and a tab which are detachable from each other. The method according to the invention in which the device according to the invention is used ensures a higher yield of nucleic acids.
    Type: Grant
    Filed: October 30, 2008
    Date of Patent: February 10, 2015
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Maximilian Ruhstorfer, Bernd Buchberger, Horst Donner, Alois Rainer
  • Patent number: 8735083
    Abstract: The present invention deals with reagents and compositions capable of effectively inhibiting peroxidase activity. According to the invention, peroxidase enzymatic activity is blocked with an acidic aqueous solution of a protein denaturing agent. preferred protein denaturing agents are detergents and chaotropic substances.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: May 27, 2014
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Manfred Watzele, Bernd Buchberger, Claudia Kirr
  • Publication number: 20130288926
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Application
    Filed: June 17, 2011
    Publication date: October 31, 2013
    Applicant: HYGLOS INVEST GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Patent number: 8062843
    Abstract: The invention provides the use of water-miscible liquid cyclic acetals for adsorbing a nucleic acid to a solid phase such as a substrate with a silica surface. To this end, the invention also provides compositions comprising said acetals. Methods are disclosed and claimed to purify nucleic acids from samples, as well as kits useful for performing these methods. The nucleic acids purified by a method of the invention are suited for assays aiming at the detection of a target nucleic acid.
    Type: Grant
    Filed: June 9, 2009
    Date of Patent: November 22, 2011
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Horst Donner, Frank Bergmann, Nina Lassonczyk, Bernd Buchberger
  • Publication number: 20100256349
    Abstract: The invention concerns a method for isolating and purifying nucleic acids from large sample volumes and a device suitable for this. The device comprises a funnel, a separating column, and a tab which are detachable from each other. The method according to the invention in which the device according to the invention is used ensures a higher yield of nucleic acids.
    Type: Application
    Filed: October 30, 2008
    Publication date: October 7, 2010
    Inventors: Maximilian Ruhstorfer, Bernd Buchberger, Horst Donner, Alois Rainer
  • Publication number: 20100204050
    Abstract: The present invention provides a method for the isolation and analysis of a target nucleic acid, the target nucleic acid being present in a sample of genomic DNA, comprising the steps of a) fragmentation of the genomic DNA, b) hybridization of the genomic DNA on a nucleic acid solid support, the solid support comprising a plurality of oligonucleotide probes, the probes being characterized in that each probe is at least partially complementary to the sequence of the target nucleic acid or its complement, under hybridization conditions, characterized in that the plurality of probes hybridizes to fragments of the target nucleic acid but does not hybridize to other nucleic acids which are present in the sample, c) stripping off the target molecules hybridized to the nucleic acid array, d) overlap extension synthesis in order to generate double stranded overlap extension synthesis product, e) fragment polishing, and f) adaptor ligation.
    Type: Application
    Filed: January 19, 2010
    Publication date: August 12, 2010
    Inventors: Horst Donner, Bernd Buchberger
  • Patent number: 7767292
    Abstract: The invention relates to a fired, fire resistant (refractory) ceramic product.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: August 3, 2010
    Assignee: Refractory Intellectual Property GmbH & Co. KG
    Inventors: Boro Djuricic, Bernd Buchberger, Klaus Santowski, Franz Koeck
  • Publication number: 20100086923
    Abstract: The invention provides the use of water-miscible liquid cyclic acetals for adsorbing a nucleic acid to a solid phase such as a substrate with a silica surface. To this end, the invention also provides compositions comprising said acetals. Methods are disclosed and claimed to purify nucleic acids from samples, as well as kits useful for performing these methods. The nucleic acids purified by a method of the invention are suited for assays aiming at the detection of a target nucleic acid.
    Type: Application
    Filed: June 9, 2009
    Publication date: April 8, 2010
    Inventors: Horst Donner, Frank Bergmann, Nina Lassonczyk, Bernd Buchberger
  • Publication number: 20090304673
    Abstract: The present invention relates to a method of treatment of an inflammatory disease, in particular sepsis, in particular sepsis caused by gram-positive bacteria, wherein the method comprises the step of administering to a subject in need thereof a sufficient amount of bacterial cell wall degrading enzymes. The present invention relates further to pharmaceutical compositions comprising bacterial cell wall degrading enzymes.
    Type: Application
    Filed: June 10, 2009
    Publication date: December 10, 2009
    Inventors: Bernd Buchberger, Holger Grallert, Ingrid Wanninger
  • Patent number: 7528085
    Abstract: The invention relates to a fired refractory ceramic product and a batch that can be used to produce said product. Both the batch (the mixture) and the prepared fired product contain spinels consisting of MgO and Al2O3.
    Type: Grant
    Filed: January 19, 2005
    Date of Patent: May 5, 2009
    Assignee: Refractory Intellectual Property GmbH & Co. KG
    Inventors: Bernd Buchberger, Roland Nilica